Breakthrough device aims to slash death risk in delicate heart surgery

NCT ID NCT05666713

Completed Disease control Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Source: ClinicalTrials.gov ↗

Summary

This study tested a new, purpose-built tool called TELLTALE designed to make a common heart valve replacement procedure (TAVR) safer. The tool is meant to prevent a rare but deadly complication where a flap of tissue blocks blood flow to the heart. Researchers enrolled 90 adults at high risk for this complication to see if the new device was effective and safe to use during their valve replacement surgery.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States
California Pacific Med Ctr

San Francisco, California, 94109, United States
Carilion Medical Center

Roanoke, Virginia, 24014, United States
Emory University

Atlanta, Georgia, 30308, United States
Medstar WHC

Washington D.C., District of Columbia, 20010, United States
Montefiore Medical Center

The Bronx, New York, 10467, United States
Rochester Regional Health

Rochester, New York, 14621, United States
St. Francis Hospital and Heart Center

Roslyn, New York, 11576, United States
University of Colorado Health

Fort Collins, Colorado, 80528, United States
University of Washington Heart Institute

Seattle, Washington, 98195, United States

Conditions

Explore the condition pages connected to this study.

AORTIC VALVE FAILURE VALVULAR HEART DISEASE